Skip to content
2000
Volume 25, Issue 13
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873

Abstract

Background

Research on RNA in diabetic retinopathy (DR) has received increasing attention in recent years. However, there is a lack of comprehensive and systematic research on the current status and future direction of RNA research in DR. Therefore, this study used bibliometric analysis to summarize the global trends and current status of DR RNA research to date.

Methods

We searched the Web of Science for studies related to DR RNA research before July 2024 and then used CiteSpace and VOSviewer to generate knowledge visualization maps.

Results

A total of 1,103 articles related to RNA research in DR were retrieved. China has the most articles, followed by the USA and Japan. Wayne State University, Nanjing Medical University, and Shanghai Jiao Tong University were the three most productive institutions. Investigative Ophthalmology & Visual Science was the most popular journal in this field. Kowluru, Renu A from Wayne State University published the most number of articles. Keyword analysis showed that the research hotspot in this field is the role of miRNAs in apoptosis and neovascularization in DR. Non-coding RNAs and extracellular vesicles are future research trends.

Conclusion

The results of this bibliometric study provide information on the current status and trends in the field of RNA research in DR. RNA research could lead to new diagnostic methods and therapeutic strategies for DR. Our findings can help researchers understand the current status of RNA research in DR and identify new directions for further research.

This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/emiddt/10.2174/0118715303358069241213151650
2025-01-03
2026-03-05
Loading full text...

Full text loading...

/deliver/fulltext/emiddt/25/13/EMIDDT-25-13-03.html?itemId=/content/journals/emiddt/10.2174/0118715303358069241213151650&mimeType=html&fmt=ahah

References

  1. SaeedM. SharifA. HassanS.U. AkhtarB. MuhammadF. MalikM. Cyperus iria aqueous-ethanol extract ameliorated hyperglycemia, oxidative stress, and regulated inflammatory cytokines in streptozotocin-induced diabetic rats.Environ. Sci. Pollut. Res. Int.20222934769478410.1007/s11356‑021‑15917‑934417690
    [Google Scholar]
  2. AsgharA. SharifA. AwanS.J. AkhtarB. AkhtarM.F. AliS.S. Ficus johannis Boiss. leaves ethanolic extract ameliorate streptozotocin-induced diabetes in rats by upregulating the expressions of GCK, GLUT4, and IGF and downregulating G6P.Environ. Sci. Pollut. Res. Int.20233017491084912410.1007/s11356‑023‑25765‑436773254
    [Google Scholar]
  3. LinK.Y. HsihW.H. LinY.B. WenC.Y. ChangT.J. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy.J. Diabetes Investig.20211281322132510.1111/jdi.1348033316144
    [Google Scholar]
  4. SunH. SaeediP. KarurangaS. PinkepankM. OgurtsovaK. DuncanB.B. SteinC. BasitA. ChanJ.C.N. MbanyaJ.C. PavkovM.E. RamachandaranA. WildS.H. JamesS. HermanW.H. ZhangP. BommerC. KuoS. BoykoE.J. MaglianoD.J. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.Diabetes Res. Clin. Pract.202218310911910.1016/j.diabres.2021.10911934879977
    [Google Scholar]
  5. ZegeyeA.F. TemachuY.Z. MekonnenC.K. Prevalence and factors associated with Diabetes retinopathy among type 2 diabetic patients at Northwest Amhara Comprehensive Specialized Hospitals, Northwest Ethiopia 2021.BMC Ophthalmol.2023231910.1186/s12886‑022‑02746‑836604682
    [Google Scholar]
  6. LeeS.W.H. NgK.Y. ChinW.K. The impact of sleep amount and sleep quality on glycemic control in type 2 diabetes: A systematic review and meta-analysis.Sleep Med. Rev.2017319110110.1016/j.smrv.2016.02.00126944909
    [Google Scholar]
  7. ChungF. SubramanyamR. LiaoP. SasakiE. ShapiroC. SunY. High STOP-Bang score indicates a high probability of obstructive sleep apnoea.Br. J. Anaesth.2012108576877510.1093/bja/aes02222401881
    [Google Scholar]
  8. CheungN. MitchellP. WongT.Y. Diabetic retinopathy.Lancet2010376973512413610.1016/S0140‑6736(09)62124‑320580421
    [Google Scholar]
  9. GemayelM.C. BhatwadekarA.D. CiullaT. RNA therapeutics for retinal diseases.Expert Opin. Biol. Ther.202121560361310.1080/14712598.2021.185636533307874
    [Google Scholar]
  10. HeM. WangW. YuH. WangD. CaoD. ZengY. WuQ. ZhongP. ChengZ. HuY. ZhangL. Comparison of expression profiling of circular RNAs in vitreous humour between diabetic retinopathy and non-diabetes mellitus patients.Acta Diabetol.202057447948910.1007/s00592‑019‑01448‑w31749049
    [Google Scholar]
  11. PlataniaC.B.M. MaistoR. TrottaM.C. D’AmicoM. RossiS. GesualdoC. D’AmicoG. BaltaC. HermanH. HermeneanA. FerraraccioF. PanareseI. DragoF. BucoloC. Retinal and circulating mi RNA expression patterns in diabetic retinopathy: An in silico and in vivo approach.Br. J. Pharmacol.2019176132179219410.1111/bph.1466530883703
    [Google Scholar]
  12. WangJ. GaoX. LiuJ. WangJ. ZhangY. ZhangT. ZhangH. Effect of intravitreal conbercept treatment on the expression of long noncoding RNAs and mRNAs in proliferative diabetic retinopathy patients.Acta Ophthalmol.2019976e902e91210.1111/aos.1408330900812
    [Google Scholar]
  13. DwivediS. PurohitP. SharmaP. MicroRNAs and diseases: Promising biomarkers for diagnosis and therapeutics.Indian J. Clin. Biochem.201934324324510.1007/s12291‑019‑00844‑x31391712
    [Google Scholar]
  14. SadashivS. SharmaP. DwivediS. TiwariS. SinghP.K. PalA. KumarS. Micro (mi) RNA and diabetic retinopathy.Indian J. Clin. Biochem.202237326727410.1007/s12291‑021‑01018‑435873619
    [Google Scholar]
  15. ZhuK. HuX. ChenH. LiF. YinN. LiuA.L. ShanK. QinY.W. HuangX. ChangQ. XuG.Z. WangZ. Downregulation of circRNA DMNT3B contributes to diabetic retinal vascular dysfunction through targeting miR-20b-5p and BAMBI.EBioMedicine20194934135310.1016/j.ebiom.2019.10.00431636010
    [Google Scholar]
  16. ShanK. LiuC. LiuB.H. ChenX. DongR. LiuX. ZhangY.Y. LiuB. ZhangS.J. WangJ.J. ZhangS.H. WuJ.H. ZhaoC. YanB. Circular noncoding RNA HIPK3 mediates retinal vascular dysfunction in Diabetes Mellitus.Circulation2017136171629164210.1161/CIRCULATIONAHA.117.02900428860123
    [Google Scholar]
  17. LengY. LiX.J. LiC-Y. BaiD. Insights into stem cell therapy for diabetic retinopathy: A bibliometric and visual analysis.Neural Regen. Res.202116117217810.4103/1673‑5374.28697432788473
    [Google Scholar]
  18. WangR. ZuoG. LiK. LiW. XuanZ. HanY. YangW. Systematic bibliometric and visualized analysis of research hotspots and trends on the application of artificial intelligence in diabetic retinopathy.Front. Endocrinol. (Lausanne)202213103642610.3389/fendo.2022.103642636387891
    [Google Scholar]
  19. DarroudiM. GholamiM. RezayiM. KhazaeiM. An overview and bibliometric analysis on the colorectal cancer therapy by magnetic functionalized nanoparticles for the responsive and targeted drug delivery.J. Nanobiotechnology202119139910.1186/s12951‑021‑01150‑634844632
    [Google Scholar]
  20. ZhiguoF. JiW. ShenyuanC. GuoyouZ. ChenK. HuiQ. WenrongX. ZhaiX. A swift expanding trend of extracellular vesicles in spinal cord injury research: A bibliometric analysis.J. Nanobiotechnology202321128910.1186/s12951‑023‑02051‑637612689
    [Google Scholar]
  21. GarfieldE. The history and meaning of the journal impact factor.JAMA20062951909310.1001/jama.295.1.9016391221
    [Google Scholar]
  22. PeplowP.V. MartinezB. MicroRNAs as biomarkers of diabetic retinopathy and disease progression.Neural Regen. Res.201914111858186910.4103/1673‑5374.25960231290435
    [Google Scholar]
  23. GongQ. SuG. Roles of miRNAs and long noncoding RNAs in the progression of diabetic retinopathy.Biosci. Rep.2017376BSR2017115710.1042/BSR2017115729074557
    [Google Scholar]
  24. MastropasquaR. TotoL. CipolloneF. SantovitoD. CarpinetoP. MastropasquaL. Role of microRNAs in the modulation of diabetic retinopathy.Prog. Retin. Eye Res.2014439210710.1016/j.preteyeres.2014.07.00325128741
    [Google Scholar]
  25. WangW. LoA.C.Y. Diabetic retinopathy: Pathophysiology and treatments.Int. J. Mol. Sci.2018196181610.3390/ijms1906181629925789
    [Google Scholar]
  26. RübsamA. ParikhS. FortP. Role of inflammation in diabetic retinopathy.Int. J. Mol. Sci.201819494210.3390/ijms1904094229565290
    [Google Scholar]
  27. KowluruR.A. MohammadG. Epigenetics and mitochondrial stability in the metabolic memory phenomenon associated with continued progression of diabetic retinopathy.Sci. Rep.2020101665510.1038/s41598‑020‑63527‑132313015
    [Google Scholar]
  28. KowluruR.A. MohammadG. Mitochondrial fragmentation in a high homocysteine environment in diabetic retinopathy.Antioxidants202211236510.3390/antiox1102036535204246
    [Google Scholar]
  29. MishraM. KowluruR.A. Role of PARP-1 as a novel transcriptional regulator of MMP-9 in diabetic retinopathy.Biochim. Biophys. Acta Mol. Basis Dis.2017186371761176910.1016/j.bbadis.2017.04.02428478229
    [Google Scholar]
  30. MohammadG. KumarJ. KowluruR.A. Mitochondrial genome-encoded long noncoding RNA cytochrome B and mitochondrial dysfunction in diabetic retinopathy.Antioxid. Redox Signal.20233913-1581782810.1089/ars.2023.030337464864
    [Google Scholar]
  31. YeE.A. LiuL. SteinleJ.J. miR-15a/16 inhibits TGF-β3/VEGF signaling and increases retinal endothelial cell barrier proteins.Vision Res.2017139232910.1016/j.visres.2017.07.00728774775
    [Google Scholar]
  32. YeE.A. SteinleJ.J. miR-146a attenuates inflammatory pathways mediated by TLR4/NF-κ B and TNFα to protect primary human retinal microvascular endothelial cells grown in high glucose.Mediators Inflamm.201620161910.1155/2016/395845326997759
    [Google Scholar]
  33. YanB. YaoJ. LiuJ.Y. LiX.M. WangX.Q. LiY.J. TaoZ.F. SongY.C. ChenQ. JiangQ. lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA.Circ. Res.201511671143115610.1161/CIRCRESAHA.116.30551025587098
    [Google Scholar]
  34. ChenQ. QiuF. ZhouK. MatlockH.G. TakahashiY. RajalaR.V.S. YangY. MoranE. MaJ. Pathogenic role of microRNA-21 in diabetic retinopathy through downregulation of PPARα.Diabetes20176661671168210.2337/db16‑124628270521
    [Google Scholar]
  35. BiswasS. ThomasA.A. ChenS. Aref-EshghiE. FengB. GonderJ. SadikovicB. ChakrabartiS. MALAT1: An epigenetic regulator of inflammation in diabetic retinopathy.Sci. Rep.201881652610.1038/s41598‑018‑24907‑w29695738
    [Google Scholar]
  36. ThomasA.A. BiswasS. FengB. ChenS. GonderJ. ChakrabartiS. lncRNA H19 prevents endothelial–mesenchymal transition in diabetic retinopathy.Diabetologia201962351753010.1007/s00125‑018‑4797‑630612136
    [Google Scholar]
  37. PoyM.N. EliassonL. KrutzfeldtJ. KuwajimaS. MaX. MacDonaldP.E. PfefferS. TuschlT. RajewskyN. RorsmanP. StoffelM. A pancreatic islet-specific microRNA regulates insulin secretion.Nature2004432701422623010.1038/nature0307615538371
    [Google Scholar]
  38. WangQ. LiuN. YangX. TuL. ZhangX. Small RNA-mediated responses to low- and high-temperature stresses in cotton.Sci. Rep.2016613555810.1038/srep3555827752116
    [Google Scholar]
  39. MendellJ.T. OlsonE.N. MicroRNAs in stress signaling and human disease.Cell201214861172118710.1016/j.cell.2012.02.00522424228
    [Google Scholar]
  40. WanW. LongY. JinX. LiQ. WanW. LiuH. ZhuY. Protective role of microRNA-200a in diabetic retinopathy through downregulation of PDLIM1.J. Inflamm. Res.2021142411242410.2147/JIR.S30354034113148
    [Google Scholar]
  41. LiuQ. LiuC. DongY. LiH. RenJ. Circ_NNT suppresses the apoptosis and inflammation in glucose-induced human retinal pigment epithelium by regulating miR-320b/TIMP3 axis in diabetic retinopathy.Clin. Immunol.202223810902310.1016/j.clim.2022.10902335477026
    [Google Scholar]
  42. XuZ. TianN. LiS. LiK. GuoH. ZhangH. JinH. AnM. YuX. Extracellular vesicles secreted from mesenchymal stem cells exert anti-apoptotic and anti-inflammatory effects via transmitting microRNA-18b in rats with diabetic retinopathy.Int. Immunopharmacol.2021101Pt B10823410.1016/j.intimp.2021.10823434655847
    [Google Scholar]
  43. KaurP. KotruS. SinghS. MunshiA. miRNA signatures in diabetic retinopathy and nephropathy: Delineating underlying mechanisms.J. Physiol. Biochem.2022781193710.1007/s13105‑021‑00867‑035098434
    [Google Scholar]
  44. YangY. LiuY. LiY. ChenZ. XiongY. ZhouT. TaoW. XuF. YangH. Ylä-HerttualaS. ChaurasiaS.S. AdamW.C. YangK. MicroRNA-15b targets VEGF and inhibits angiogenesis in proliferative diabetic retinopathy.J. Clin. Endocrinol. Metab.2020105113404341510.1210/clinem/dgaa53832797181
    [Google Scholar]
  45. McArthurK. FengB. WuY. ChenS. ChakrabartiS. MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy.Diabetes20116041314132310.2337/db10‑155721357793
    [Google Scholar]
  46. WangP. LiC. DengY. YuQ. MengX. JiangT. WangQ. FuY. Effect of plasma-derived extracellular vesicles on angiogenesis and the ensuing proliferative diabetic retinopathy through a miR-30b-dependent mechanism.Diabetol. Metab. Syndr.202214118810.1186/s13098‑022‑00937‑336494734
    [Google Scholar]
  47. LuoY. LiC. Advances in research related to MicroRNA for diabetic retinopathy.J. Diabetes Res.2024202412110.1155/2024/852048938375094
    [Google Scholar]
  48. Ghasemi FalavarjaniK. NguyenQ.D. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: A review of literature.Eye (Lond.)201327778779410.1038/eye.2013.10723722722
    [Google Scholar]
  49. ChangX. ZhuG. CaiZ. WangY. LianR. TangX. MaC. FuS. miRNA, lncRNA and circRNA: Targeted molecules full of therapeutic prospects in the development of diabetic retinopathy.Front. Endocrinol.20211277155210.3389/fendo.2021.77155234858342
    [Google Scholar]
  50. ShafabakhshR. MirhosseiniN. ChaichianS. MoazzamiB. MahdizadehZ. AsemiZ. Could circRNA be a new biomarker for pre-eclampsia?Mol. Reprod. Dev.201986121773178010.1002/mrd.2326231475762
    [Google Scholar]
  51. ZhangC. HuJ. YuY. CircRNA is a rising star in researches of ocular diseases.Front. Cell Dev. Biol.2020885010.3389/fcell.2020.0085033015046
    [Google Scholar]
  52. ZhangS.J. ChenX. LiC.P. LiX.M. LiuC. LiuB.H. ShanK. JiangQ. ZhaoC. YanB. Identification and characterization of circular RNAs as a new class of putative biomarkers in diabetes retinopathy.Invest. Ophthalmol. Vis. Sci.201758146500650910.1167/iovs.17‑2269829288268
    [Google Scholar]
  53. ZhouH. KuangH. Circular RNAs: Novel target of diabetic retinopathy.Rev. Endocr. Metab. Disord.202122220521610.1007/s11154‑021‑09646‑033761053
    [Google Scholar]
  54. BridgesM.C. DaulagalaA.C. KourtidisA. LNCcation: lncRNA localization and function.J. Cell Biol.20212202e20200904510.1083/jcb.20200904533464299
    [Google Scholar]
  55. WangY. HuangL. WangY. LuoW. LiF. XiaoJ. QinS. WangZ. SongX. WangY. JinF. WangY. Single-cell RNA-sequencing analysis identifies host long noncoding RNA MAMDC2-AS1 as a co-factor for HSV-1 nuclear transport.Int. J. Biol. Sci.20201691586160310.7150/ijbs.4255632226304
    [Google Scholar]
  56. SunX. WongD. Long non-coding RNA-mediated regulation of glucose homeostasis and diabetes.Am. J. Cardiovasc. Dis.201662172527335687
    [Google Scholar]
  57. KitagawaM. KitagawaK. KotakeY. NiidaH. OhhataT. Cell cycle regulation by long non-coding RNAs.Cell. Mol. Life Sci.201370244785479410.1007/s00018‑013‑1423‑023880895
    [Google Scholar]
  58. BallarinoM. MorlandoM. FaticaA. BozzoniI. Non-coding RNAs in muscle differentiation and musculoskeletal disease.J. Clin. Invest.201612662021203010.1172/JCI8441927249675
    [Google Scholar]
  59. ShuH. ZhangZ. LiuJ. ChenP. YangC. WuY. WuD. CaoY. ChuY. LiL. Circular RNAs: An emerging precise weapon for diabetic nephropathy diagnosis and therapy.Biomed. Pharmacother.202316811581810.1016/j.biopha.2023.11581837939612
    [Google Scholar]
  60. ZhangW. HeY. ZhangY. CircRNA in ocular neovascular diseases: Fundamental mechanism and clinical potential.Pharmacol. Res.202319710694610.1016/j.phrs.2023.10694637797661
    [Google Scholar]
  61. TangY. BaoJ. HuJ. LiuL. XuD.Y. Circular RNA in cardiovascular disease: Expression, mechanisms and clinical prospects.J. Cell. Mol. Med.20212541817182410.1111/jcmm.1620333350091
    [Google Scholar]
  62. ZhuL. LiJ. GongY. WuQ. TanS. SunD. XuX. ZuoY. ZhaoY. WeiY.Q. WeiX.W. PengY. Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis.Mol. Cancer20191817410.1186/s12943‑019‑1000‑830940133
    [Google Scholar]
  63. ZaiouM. circRNAs signature as potential diagnostic and prognostic biomarker for Diabetes Mellitus and related cardiovascular complications.Cells20209365910.3390/cells903065932182790
    [Google Scholar]
  64. MoF. LvB. ZhaoD. XiZ. QianY. GeD. YangN. ZhangD. JiangG. GaoS. Small RNA sequencing analysis of STZ-injured pancreas reveals novel MicroRNA and transfer RNA-derived RNA with biomarker potential for Diabetes Mellitus.Int. J. Mol. Sci.202324121032310.3390/ijms24121032337373469
    [Google Scholar]
  65. JiangB. ZhangJ. SunX. YangC. ChengG. XuM. LiS. WangL. Circulating exosomal hsa_circRNA_0039480 is highly expressed in gestational diabetes mellitus and may be served as a biomarker for early diagnosis of GDM.J. Transl. Med.2022201510.1186/s12967‑021‑03195‑534980149
    [Google Scholar]
  66. QinL.L. AnM.X. LiuY.L. XuH.C. LuZ.Q. MicroRNA-126: A promising novel biomarker in peripheral blood for diabetic retinopathy.Int. J. Ophthalmol.201710453053428503423
    [Google Scholar]
  67. YangS. ZhangJ. ZengT. ZhengJ. MinJ. ChenL. Role of Circulating Exosomal miRNA-3976 in early diabetic retinopathy.Int. J. Nanomedicine2023183695370937427366
    [Google Scholar]
  68. ZhuJ. HuangJ. SunY. XuW. QianH. Emerging role of extracellular vesicles in diabetic retinopathy.Theranostics20241441631164610.7150/thno.9246338389842
    [Google Scholar]
  69. SuY. ChenJ. DongZ. ZhangY. MaR. KouJ. WangF. ShiJ. Procoagulant activity of blood and endothelial cells via phosphatidylserine exposure and microparticle delivery in patients with diabetic retinopathy.Cell. Physiol. Biochem.20184562411242010.1159/00048822829554658
    [Google Scholar]
  70. HeoJ.I. RyuJ. Exosomal noncoding RNA: A potential therapy for retinal vascular diseases.Mol. Ther. Nucleic Acids202435110212810.1016/j.omtn.2024.10212838356865
    [Google Scholar]
  71. ShughouryA. CiullaT.A. BakallB. PennesiM.E. KissS. CunninghamE.T.Jr. Genes and gene therapy in inherited retinal disease.Int. Ophthalmol. Clin.202161434510.1097/IIO.000000000000037734584043
    [Google Scholar]
  72. KhananiA.M. ThomasM.J. AzizA.A. WengC.Y. DanzigC.J. YiuG. KissS. WaheedN.K. KaiserP.K. Review of gene therapies for age-related macular degeneration.Eye (Lond.)202236230331110.1038/s41433‑021‑01842‑135017696
    [Google Scholar]
  73. BuggageR.R. BordetT. Gene therapy for uveitis.Int. Ophthalmol. Clin.202161424927010.1097/IIO.000000000000036934584061
    [Google Scholar]
  74. WangJ.H. RobertsG.E. LiuG.S. Updates on gene therapy for diabetic retinopathy.Curr. Diab. Rep.20202072210.1007/s11892‑020‑01308‑w32415508
    [Google Scholar]
  75. ZhuX. LvM. ChengT. ZhouY. YuanG. ChuY. LuanY. SongQ. HuY. Bibliometric analysis of atrial fibrillation and ion channels.Heart Rhythm20242171161116910.1016/j.hrthm.2024.01.03238280618
    [Google Scholar]
/content/journals/emiddt/10.2174/0118715303358069241213151650
Loading
/content/journals/emiddt/10.2174/0118715303358069241213151650
Loading

Data & Media loading...

Supplements

PRISMA checklist is available as supplementary material on the publisher’s website along with the published article.


  • Article Type:
    Review Article
Keyword(s): bibliometrics; CiteSpace; Diabetic retinopathy; non-coding RNA; RNA; VOSviewer
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test